- Home
- NEO vs GEL Comparison
NEO vs GEL Comparison
Compare NEO & GEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEO | GEL |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 2008 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NEO | GEL |
|---|---|---|
| Price | $17.38 | $15.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $13.38 | ★ $19.50 |
| AVG Volume (30 Days) | ★ 1.6M | 208.7K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.19% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | N/A | ★ $2,912,770,000.00 |
| Revenue This Year | $10.63 | $12.12 |
| Revenue Next Year | $9.73 | N/A |
| P/E Ratio | ★ N/A | $75.48 |
| Revenue Growth | N/A | ★ 43.60 |
| 52 Week Low | $7.07 | $13.75 |
| 52 Week High | $19.76 | $18.64 |
Technical Indicators
Market Signals| Indicator | NEO | GEL |
|---|---|---|
| Relative Strength Index (RSI) | 58.99 | 60.01 |
| Support Level | $15.72 | $14.96 |
| Resistance Level | $19.76 | $16.47 |
| Average True Range (ATR) | 0.83 | 0.35 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 42.57 | 70.48 |
Price Performance
Historical ComparisonAbout NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About GEL Genesis Energy L.P.
Genesis Energy LP focuses on the midstream segment of the crude oil and natural gas industry. It offers various services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are: Offshore pipeline transportation, Marine transportation, and Onshore transportation and services. Maximum revenue is generated from the Offshore pipeline transportation segment, which includes the transportation and processing of crude oil and natural gas in the Gulf of America. The Marine transportation segment provides waterborne transportation of petroleum products and crude oil throughout North America; and the Onshore transportation and services segment deals with crude oil logistics, sour gas processing, and sells sulfur byproducts.